These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 28860837)
21. Potential serum biomarkers for early detection of diabetic nephropathy. Motawi TK; Shehata NI; ElNokeety MM; El-Emady YF Diabetes Res Clin Pract; 2018 Feb; 136():150-158. PubMed ID: 29253627 [TBL] [Abstract][Full Text] [Related]
22. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus. Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663 [TBL] [Abstract][Full Text] [Related]
23. Biomarkers in diabetic nephropathy: Present and future. Currie G; McKay G; Delles C World J Diabetes; 2014 Dec; 5(6):763-76. PubMed ID: 25512779 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic Accuracy of Neutrophil Gelatinase-Associated Lipocalin for Predicting Early Diabetic Nephropathy in Patients with Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis. Kapoula GV; Kontou PI; Bagos PG J Appl Lab Med; 2019 Jul; 4(1):78-94. PubMed ID: 31639710 [TBL] [Abstract][Full Text] [Related]
26. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus. Shoukry A; Bdeer Sel-A; El-Sokkary RH Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579 [TBL] [Abstract][Full Text] [Related]
27. Expression of Endothelial Cell Injury Marker Cd146 Correlates with Disease Severity and Predicts the Renal Outcomes in Patients with Diabetic Nephropathy. Fan Y; Fei Y; Zheng L; Wang J; Xiao W; Wen J; Xu Y; Wang Y; He L; Guan J; Wei J; He JC; Wang N Cell Physiol Biochem; 2018; 48(1):63-74. PubMed ID: 30001528 [TBL] [Abstract][Full Text] [Related]
28. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy. Zhang J; Wang Y; Li L; Zhang R; Guo R; Li H; Han Q; Teng G; Liu F Ren Fail; 2018 Nov; 40(1):243-251. PubMed ID: 29633887 [TBL] [Abstract][Full Text] [Related]
29. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy. Zhu C; Liang QL; Hu P; Wang YM; Luo GA Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008 [TBL] [Abstract][Full Text] [Related]
30. Prevalence of diabetic nephropathy among Type 2 diabetic patients in some of the Arab countries. Aldukhayel A Int J Health Sci (Qassim); 2017; 11(1):1-4. PubMed ID: 28293155 [TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor receptor and podocin predict nephropathy progression in type 2 diabetic patients through interaction with the autophagy influencer ULK-1. El-Shazly AAA; Sallam AM; El-Hefnawy MH; El-Mesallamy HO J Diabetes Complications; 2019 Feb; 33(2):128-133. PubMed ID: 30545560 [TBL] [Abstract][Full Text] [Related]
33. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes. Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120 [TBL] [Abstract][Full Text] [Related]
34. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy. Al-Kafaji G; Al-Muhtaresh HA Mol Med Rep; 2018 Jul; 18(1):1171-1180. PubMed ID: 29845236 [TBL] [Abstract][Full Text] [Related]
35. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement. Li L; Zhang X; Li Z; Zhang R; Guo R; Yin Q; Yang L; Yue R; Su B; Huang S; Xu H; He C; Liu F J Diabetes Complications; 2017 Jan; 31(1):114-121. PubMed ID: 27838100 [TBL] [Abstract][Full Text] [Related]
36. Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy. Rossi L; Nicoletti MC; Carmosino M; Mastrofrancesco L; Di Franco A; Indrio F; Lella R; Laviola L; Giorgino F; Svelto M; Gesualdo L; Procino G J Diabetes Res; 2017; 2017():4360357. PubMed ID: 28246612 [TBL] [Abstract][Full Text] [Related]
37. Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria. Verzola D; Cappuccino L; D'Amato E; Villaggio B; Gianiorio F; Mij M; Simonato A; Viazzi F; Salvidio G; Garibotto G Kidney Int; 2014 Dec; 86(6):1229-43. PubMed ID: 24786705 [TBL] [Abstract][Full Text] [Related]
39. Roux-en-Y Esophagojejunostomy Ameliorates Renal Function Through Reduction of Renal Inflammatory and Fibrotic Markers in Diabetic Nephropathy. Wang C; He B; Piao D; Han P Obes Surg; 2016 Jul; 26(7):1402-13. PubMed ID: 26510754 [TBL] [Abstract][Full Text] [Related]
40. Biomarkers of diabetic nephropathy, the present and the future. Jim B; Santos J; Spath F; Cijiang He J Curr Diabetes Rev; 2012 Sep; 8(5):317-28. PubMed ID: 22698077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]